Ophthalmic compositions for treating ocular hypertension

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/215 (2006.01) A61K 31/38 (2006.01) A61K 31/542 (2006.01) A61K 31/5575 (2006.01)

Patent

CA 2291777

Combinations of a prostaglandin or an opthalmologically acceptable salt thereof and a topical carbonic anhydrase inhibitor or an opthalmologically acceptable salt thereof are particularly useful in the treatment of ocular hypertension and glaucoma. The combinations are characterized by an improved effect and reduced side-effects.

La présente invention concerne des combinaisons d'une prostaglandine ou d'un sel ophtalmologiquement acceptable de celle-ci, et d'un inhibiteur topique d'anhydrase carbonique ou d'un sel ophtalmologiquement acceptable de celui-ci, qui sont particulièrement utiles pour le traitement de l'hypertension oculaire et du glaucome. Ces combinaisons sont caractérisées par un effet amélioré et des effets secondaires réduits.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ophthalmic compositions for treating ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic compositions for treating ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions for treating ocular hypertension will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1352602

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.